Literature DB >> 21683809

Dynamics of polymerization shed light on the mechanisms that lead to multiple amyloid structures of the prion protein.

Maria-Teresa Alvarez-Martinez1, Pascaline Fontes, Viviana Zomosa-Signoret, Jacques-Damien Arnaud, Erwan Hingant, Laurent Pujo-Menjouet, Jean-Pierre Liautard.   

Abstract

It is generally accepted that spongiform encephalopathies result from the aggregation into amyloid of a ubiquitous protein, the so-called prion protein. As a consequence, the dynamics of amyloid formation should explain the characteristics of the prion diseases: infectivity as well as sporadic and genetic occurrence, long incubation time, species barriers and strain specificities. The success of this amyloid hypothesis is due to the good qualitative agreement of this hypothesis with the observations. However, a number of difficulties appeared when comparing quantitatively the in vitro experimental results with the theoretical models, suggesting that some differences should hide important discrepancies. We used well defined quantitative models to analyze the experimental results obtained by in vitro polymerization of the recombinant hamster prion protein. Although the dynamics of polymerization resembles a simple nucleus-dependent fibrillogenesis, neither the initial concentration dependence nor off-pathway hypothesis fit with experimental results. Furthermore, seeded polymerization starts after a long time delay suggesting the existence of a specific mechanism that takes place before nucleus formation. On the other hand, polymerization dynamics reveals a highly stochastic mechanism, the origin of which appears to be caused by nucleation heterogeneity. Moreover, the specific structures generated during nucleation are maintained during successive seeding although a clear improvement of the dynamics parameters (polymerization rate and lag time) is observed. We propose that an additional on-pathway reaction takes place before nucleation and it is responsible for the heterogeneity of structures produced during prion protein polymerization in vitro. These amyloid structures behave like prion strains. A model is proposed to explain the genesis of heterogeneity among prion amyloid.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21683809     DOI: 10.1016/j.bbapap.2011.05.016

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  11 in total

1.  Mouse prion protein polymorphism Phe-108/Val-189 affects the kinetics of fibril formation and the response to seeding: evidence for a two-step nucleation polymerization mechanism.

Authors:  Leonardo M Cortez; Jitendra Kumar; Ludovic Renault; Howard S Young; Valerie L Sim
Journal:  J Biol Chem       Date:  2013-01-02       Impact factor: 5.157

2.  Combined effects of agitation, macromolecular crowding, and interfaces on amyloidogenesis.

Authors:  Chiu Fan Lee; Sarah Bird; Michael Shaw; Létitia Jean; David J Vaux
Journal:  J Biol Chem       Date:  2012-09-17       Impact factor: 5.157

3.  Propagation of an Aβ Dodecamer Strain Involves a Three-Step Mechanism and a Key Intermediate.

Authors:  Dexter N Dean; Pratip Rana; Ryan P Campbell; Preetam Ghosh; Vijayaraghavan Rangachari
Journal:  Biophys J       Date:  2018-02-06       Impact factor: 4.033

4.  Comparisons with amyloid-β reveal an aspartate residue that stabilizes fibrils of the aortic amyloid peptide medin.

Authors:  Hannah A Davies; Jillian Madine; David A Middleton
Journal:  J Biol Chem       Date:  2015-01-22       Impact factor: 5.157

5.  The role of the unusual threonine string in the conversion of prion protein.

Authors:  Romany Abskharon; Fei Wang; Kayla J Vander Stel; Kumar Sinniah; Jiyan Ma
Journal:  Sci Rep       Date:  2016-12-16       Impact factor: 4.379

Review 6.  The Impact of Mathematical Modeling in Understanding the Mechanisms Underlying Neurodegeneration: Evolving Dimensions and Future Directions.

Authors:  A Lloret-Villas; T M Varusai; N Juty; C Laibe; N Le NovÈre; H Hermjakob; V Chelliah
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2017-01-07

7.  Insights into the Origin of Distinct Medin Fibril Morphologies Induced by Incubation Conditions and Seeding.

Authors:  Hannah A Davies; Chiu Fan Lee; Leanne Miller; Lu-Ning Liu; Jillian Madine
Journal:  Int J Mol Sci       Date:  2018-05-03       Impact factor: 5.923

8.  Amyloid core formed of full-length recombinant mouse prion protein involves sequence 127-143 but not sequence 107-126.

Authors:  Biswanath Chatterjee; Chung-Yu Lee; Chen Lin; Eric H-L Chen; Chao-Li Huang; Chien-Chih Yang; Rita P-Y Chen
Journal:  PLoS One       Date:  2013-07-03       Impact factor: 3.240

9.  An efficient kinetic model for assemblies of amyloid fibrils and its application to polyglutamine aggregation.

Authors:  Stéphanie Prigent; Annabelle Ballesta; Frédérique Charles; Natacha Lenuzza; Pierre Gabriel; Léon Matar Tine; Human Rezaei; Marie Doumic
Journal:  PLoS One       Date:  2012-11-13       Impact factor: 3.240

10.  A micellar on-pathway intermediate step explains the kinetics of prion amyloid formation.

Authors:  Erwan Hingant; Pascaline Fontes; Maria Teresa Alvarez-Martinez; Jacques-Damien Arnaud; Jean-Pierre Liautard; Laurent Pujo-Menjouet
Journal:  PLoS Comput Biol       Date:  2014-08-07       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.